Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
In Alzheimer's disease, progressive supranuclear palsy, and a number of other neurodegenerative diseases, the microtubule associated protein tau aggregates to form intracellular neurofibrillary tangles and glial tangles, abnormal structures that are part of disease pathogenesis. Disorders with...
Main Authors: | Reeteka Sud, Evan T Geller, Gerard D Schellenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116303183 |
Similar Items
-
Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
Published: (2014-01-01) -
Tau exon 10 alternative splicing and tauopathies
by: Liu Fei, et al.
Published: (2008-07-01) -
Development of an antisense-mediated exon skipping therapeutic strategy for Mucolipidosis II
by: Regina Filipa Machado Vilela
Published: (2019) -
Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
by: Derek W. Wang, et al.
Published: (2018-06-01) -
Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
by: Jessica M. Cale, et al.
Published: (2021-03-01)